Morningside Group For Profit

The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.

Industry: Omics-Based Biomarkers
Estimated Revenue: $4.9Mper year
Technology: Other type
Number Of Exists: 32
Headquarters: Newton Center, Massachusetts, United States
Investor Type: University Program
Employee Number: 51-100
Investors Number: 154
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Founded Date: 1986-01-01